GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Immunovia AB (OSTO:IMMNOV) » Definitions » Pretax Margin %

Immunovia AB (OSTO:IMMNOV) Pretax Margin % : 674.73% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Immunovia AB Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Immunovia AB's Pre-Tax Income for the three months ended in Dec. 2024 was kr3.07 Mil. Immunovia AB's Revenue for the three months ended in Dec. 2024 was kr0.46 Mil. Therefore, Immunovia AB's pretax margin for the quarter that ended in Dec. 2024 was 674.73%.

The historical rank and industry rank for Immunovia AB's Pretax Margin % or its related term are showing as below:

OSTO:IMMNOV' s Pretax Margin % Range Over the Past 10 Years
Min: -40340.61   Med: -19063.15   Max: -3601.95
Current: -8221.38


OSTO:IMMNOV's Pretax Margin % is ranked worse than
97.65% of 213 companies
in the Medical Diagnostics & Research industry
Industry Median: -6.97 vs OSTO:IMMNOV: -8221.38

Immunovia AB Pretax Margin % Historical Data

The historical data trend for Immunovia AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunovia AB Pretax Margin % Chart

Immunovia AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -40,340.61 -18,479.38 -14,680.52 -19,646.92 -8,221.37

Immunovia AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31,625.81 -1,888.46 -30,114.12 -21,731.06 674.73

Competitive Comparison of Immunovia AB's Pretax Margin %

For the Diagnostics & Research subindustry, Immunovia AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunovia AB's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Immunovia AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Immunovia AB's Pretax Margin % falls into.


;
;

Immunovia AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Immunovia AB's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-76.541/0.931
=-8,221.37 %

Immunovia AB's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=3.07/0.455
=674.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immunovia AB  (OSTO:IMMNOV) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Immunovia AB Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Immunovia AB's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunovia AB Business Description

Traded in Other Exchanges
Address
Medicon Village, Scheelevagen 8, Lund, SWE, 223 63
Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The company is currently developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer.

Immunovia AB Headlines

No Headlines